Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 559

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 559
---
 and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were nounrecognized tax benefits as of September 30, 2024 and December 31, 2023. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. Noamounts were accrued for the payment interest and penalties as of September 30, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. NOTE 3 — INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 6,000,000Units at a price of $ 10.00per Unit. On February 17, 2023, the underwriters exercised their over -allotmentoption to purchase an additional 900,000Units. Each Unit consists of oneshare of common stock, oneredeemable warrant entitling the holder thereof to purchase oneshare of Common Stock at a price of $ 11.50per share, subject to adjustment, and oneright which entitles the holder thereof to receive one -tenth(1/10) of a share of common stock (see Note 6). Each warrant will become exercisable 30 daysafter the consummation of an initial business combination, and will expire fiveyears after the completion of an initial business combination, or earlier upon redemption or liquidation. Each right entitles the holder thereof to receive one -tenth(1/10) of a share of common stock upon the consummation of an initial business combination, as described in more detail below. Each tenrights entitle the holder thereof to receive one share of common stock at the closing of a business combination. F-15 BELLEVUE LIFE SCIENCES ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2024 (UNAUDITED)